2203 lines
82 KiB
JavaScript
2203 lines
82 KiB
JavaScript
// HPV Vaccine Coverage and Cervical Cancer Data (2024)
|
|
// Data represents global HPV vaccination programs and cervical cancer burden
|
|
// Sources: WHO, GAVI, HPV Information Centre, Global Cancer Observatory
|
|
|
|
const hpvVaccineData = {
|
|
"type": "FeatureCollection",
|
|
"features": [
|
|
// HIGH-INCOME COUNTRIES - HIGH COVERAGE (>75%)
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [-95.7129, 37.0902] },
|
|
"properties": {
|
|
"name": "United States",
|
|
"hpv_coverage_2024": 76,
|
|
"vaccine_program_started": 2006,
|
|
"target_age": "11-12",
|
|
"cervical_cancer_incidence": 7.5,
|
|
"cervical_cancer_mortality": 2.3,
|
|
"income_level": "high",
|
|
"lives_saved_projected": 6200,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 4300
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [-106.3468, 56.1304] },
|
|
"properties": {
|
|
"name": "Canada",
|
|
"hpv_coverage_2024": 85,
|
|
"vaccine_program_started": 2007,
|
|
"target_age": "9-13",
|
|
"cervical_cancer_incidence": 6.9,
|
|
"cervical_cancer_mortality": 1.8,
|
|
"income_level": "high",
|
|
"lives_saved_projected": 850,
|
|
"gender_policy": "girls-and-boys",
|
|
"annual_deaths": 410
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [-3.7038, 40.4168] },
|
|
"properties": {
|
|
"name": "Spain",
|
|
"hpv_coverage_2024": 91,
|
|
"vaccine_program_started": 2007,
|
|
"target_age": "12",
|
|
"cervical_cancer_incidence": 7.3,
|
|
"cervical_cancer_mortality": 1.9,
|
|
"income_level": "high",
|
|
"lives_saved_projected": 620,
|
|
"gender_policy": "girls-and-boys",
|
|
"annual_deaths": 520
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [2.2137, 46.2276] },
|
|
"properties": {
|
|
"name": "France",
|
|
"hpv_coverage_2024": 46,
|
|
"vaccine_program_started": 2007,
|
|
"target_age": "11-14",
|
|
"cervical_cancer_incidence": 7.5,
|
|
"cervical_cancer_mortality": 1.7,
|
|
"income_level": "high",
|
|
"lives_saved_projected": 2400,
|
|
"gender_policy": "girls-and-boys",
|
|
"annual_deaths": 660
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [10.4515, 51.1657] },
|
|
"properties": {
|
|
"name": "Germany",
|
|
"hpv_coverage_2024": 54,
|
|
"vaccine_program_started": 2007,
|
|
"target_age": "9-14",
|
|
"cervical_cancer_incidence": 7.6,
|
|
"cervical_cancer_mortality": 2.2,
|
|
"income_level": "high",
|
|
"lives_saved_projected": 2800,
|
|
"gender_policy": "girls-and-boys",
|
|
"annual_deaths": 1100
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [12.5674, 41.8719] },
|
|
"properties": {
|
|
"name": "Italy",
|
|
"hpv_coverage_2024": 71,
|
|
"vaccine_program_started": 2007,
|
|
"target_age": "11-12",
|
|
"cervical_cancer_incidence": 6.6,
|
|
"cervical_cancer_mortality": 1.4,
|
|
"income_level": "high",
|
|
"lives_saved_projected": 1200,
|
|
"gender_policy": "girls-and-boys",
|
|
"annual_deaths": 500
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [-0.1276, 51.5074] },
|
|
"properties": {
|
|
"name": "United Kingdom",
|
|
"hpv_coverage_2024": 89,
|
|
"vaccine_program_started": 2008,
|
|
"target_age": "12-13",
|
|
"cervical_cancer_incidence": 9.6,
|
|
"cervical_cancer_mortality": 2.5,
|
|
"income_level": "high",
|
|
"lives_saved_projected": 980,
|
|
"gender_policy": "girls-and-boys",
|
|
"annual_deaths": 890
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [133.7751, -25.2744] },
|
|
"properties": {
|
|
"name": "Australia",
|
|
"hpv_coverage_2024": 92,
|
|
"vaccine_program_started": 2007,
|
|
"target_age": "12-13",
|
|
"cervical_cancer_incidence": 6.1,
|
|
"cervical_cancer_mortality": 1.4,
|
|
"income_level": "high",
|
|
"lives_saved_projected": 420,
|
|
"gender_policy": "girls-and-boys",
|
|
"annual_deaths": 210
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [174.8860, -40.9006] },
|
|
"properties": {
|
|
"name": "New Zealand",
|
|
"hpv_coverage_2024": 78,
|
|
"vaccine_program_started": 2008,
|
|
"target_age": "11-12",
|
|
"cervical_cancer_incidence": 7.5,
|
|
"cervical_cancer_mortality": 2.1,
|
|
"income_level": "high",
|
|
"lives_saved_projected": 85,
|
|
"gender_policy": "girls-and-boys",
|
|
"annual_deaths": 60
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [138.2529, 36.2048] },
|
|
"properties": {
|
|
"name": "Japan",
|
|
"hpv_coverage_2024": 18,
|
|
"vaccine_program_started": 2009,
|
|
"target_age": "12-16",
|
|
"cervical_cancer_incidence": 10.1,
|
|
"cervical_cancer_mortality": 3.0,
|
|
"income_level": "high",
|
|
"lives_saved_projected": 8200,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 2900
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [127.7669, 35.9078] },
|
|
"properties": {
|
|
"name": "South Korea",
|
|
"hpv_coverage_2024": 82,
|
|
"vaccine_program_started": 2016,
|
|
"target_age": "12",
|
|
"cervical_cancer_incidence": 11.3,
|
|
"cervical_cancer_mortality": 3.2,
|
|
"income_level": "high",
|
|
"lives_saved_projected": 1100,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 970
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [15.2551, 54.5260] },
|
|
"properties": {
|
|
"name": "Poland",
|
|
"hpv_coverage_2024": 19,
|
|
"vaccine_program_started": 2023,
|
|
"target_age": "11-12",
|
|
"cervical_cancer_incidence": 10.9,
|
|
"cervical_cancer_mortality": 4.4,
|
|
"income_level": "high",
|
|
"lives_saved_projected": 3400,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 1900
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [25.7488, 45.9432] },
|
|
"properties": {
|
|
"name": "Romania",
|
|
"hpv_coverage_2024": 8,
|
|
"vaccine_program_started": 2008,
|
|
"target_age": "11",
|
|
"cervical_cancer_incidence": 28.6,
|
|
"cervical_cancer_mortality": 13.2,
|
|
"income_level": "upper-middle",
|
|
"lives_saved_projected": 5800,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 1900
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [25.0136, 60.1695] },
|
|
"properties": {
|
|
"name": "Finland",
|
|
"hpv_coverage_2024": 88,
|
|
"vaccine_program_started": 2013,
|
|
"target_age": "10-12",
|
|
"cervical_cancer_incidence": 4.8,
|
|
"cervical_cancer_mortality": 1.2,
|
|
"income_level": "high",
|
|
"lives_saved_projected": 90,
|
|
"gender_policy": "girls-and-boys",
|
|
"annual_deaths": 40
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [18.6435, 60.1282] },
|
|
"properties": {
|
|
"name": "Sweden",
|
|
"hpv_coverage_2024": 85,
|
|
"vaccine_program_started": 2010,
|
|
"target_age": "10-12",
|
|
"cervical_cancer_incidence": 9.6,
|
|
"cervical_cancer_mortality": 2.7,
|
|
"income_level": "high",
|
|
"lives_saved_projected": 230,
|
|
"gender_policy": "girls-and-boys",
|
|
"annual_deaths": 160
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [8.4689, 47.5596] },
|
|
"properties": {
|
|
"name": "Switzerland",
|
|
"hpv_coverage_2024": 63,
|
|
"vaccine_program_started": 2008,
|
|
"target_age": "11-14",
|
|
"cervical_cancer_incidence": 5.8,
|
|
"cervical_cancer_mortality": 1.3,
|
|
"income_level": "high",
|
|
"lives_saved_projected": 220,
|
|
"gender_policy": "girls-and-boys",
|
|
"annual_deaths": 70
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [5.2913, 52.1326] },
|
|
"properties": {
|
|
"name": "Netherlands",
|
|
"hpv_coverage_2024": 61,
|
|
"vaccine_program_started": 2009,
|
|
"target_age": "12",
|
|
"cervical_cancer_incidence": 8.0,
|
|
"cervical_cancer_mortality": 2.1,
|
|
"income_level": "high",
|
|
"lives_saved_projected": 580,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 210
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [4.4699, 50.5039] },
|
|
"properties": {
|
|
"name": "Belgium",
|
|
"hpv_coverage_2024": 77,
|
|
"vaccine_program_started": 2007,
|
|
"target_age": "11-12",
|
|
"cervical_cancer_incidence": 8.3,
|
|
"cervical_cancer_mortality": 2.0,
|
|
"income_level": "high",
|
|
"lives_saved_projected": 290,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 130
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [10.4515, 56.2639] },
|
|
"properties": {
|
|
"name": "Denmark",
|
|
"hpv_coverage_2024": 84,
|
|
"vaccine_program_started": 2009,
|
|
"target_age": "12",
|
|
"cervical_cancer_incidence": 11.3,
|
|
"cervical_cancer_mortality": 3.3,
|
|
"income_level": "high",
|
|
"lives_saved_projected": 180,
|
|
"gender_policy": "girls-and-boys",
|
|
"annual_deaths": 110
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [10.7522, 59.9139] },
|
|
"properties": {
|
|
"name": "Norway",
|
|
"hpv_coverage_2024": 80,
|
|
"vaccine_program_started": 2009,
|
|
"target_age": "12",
|
|
"cervical_cancer_incidence": 11.6,
|
|
"cervical_cancer_mortality": 2.9,
|
|
"income_level": "high",
|
|
"lives_saved_projected": 150,
|
|
"gender_policy": "girls-and-boys",
|
|
"annual_deaths": 90
|
|
}
|
|
},
|
|
|
|
// UPPER-MIDDLE INCOME - MODERATE COVERAGE (40-75%)
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [103.8198, 1.3521] },
|
|
"properties": {
|
|
"name": "Singapore",
|
|
"hpv_coverage_2024": 87,
|
|
"vaccine_program_started": 2019,
|
|
"target_age": "13",
|
|
"cervical_cancer_incidence": 8.2,
|
|
"cervical_cancer_mortality": 2.8,
|
|
"income_level": "high",
|
|
"lives_saved_projected": 110,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 95
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [-99.1332, 19.4326] },
|
|
"properties": {
|
|
"name": "Mexico",
|
|
"hpv_coverage_2024": 68,
|
|
"vaccine_program_started": 2012,
|
|
"target_age": "11",
|
|
"cervical_cancer_incidence": 13.9,
|
|
"cervical_cancer_mortality": 6.5,
|
|
"income_level": "upper-middle",
|
|
"lives_saved_projected": 5200,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 4800
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [-47.8825, -15.7942] },
|
|
"properties": {
|
|
"name": "Brazil",
|
|
"hpv_coverage_2024": 71,
|
|
"vaccine_program_started": 2014,
|
|
"target_age": "9-14",
|
|
"cervical_cancer_incidence": 15.4,
|
|
"cervical_cancer_mortality": 7.4,
|
|
"income_level": "upper-middle",
|
|
"lives_saved_projected": 8300,
|
|
"gender_policy": "girls-and-boys",
|
|
"annual_deaths": 6800
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [-58.3816, -34.6037] },
|
|
"properties": {
|
|
"name": "Argentina",
|
|
"hpv_coverage_2024": 82,
|
|
"vaccine_program_started": 2011,
|
|
"target_age": "11",
|
|
"cervical_cancer_incidence": 17.4,
|
|
"cervical_cancer_mortality": 7.2,
|
|
"income_level": "upper-middle",
|
|
"lives_saved_projected": 1900,
|
|
"gender_policy": "girls-and-boys",
|
|
"annual_deaths": 1900
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [-70.6693, -33.4489] },
|
|
"properties": {
|
|
"name": "Chile",
|
|
"hpv_coverage_2024": 85,
|
|
"vaccine_program_started": 2014,
|
|
"target_age": "9",
|
|
"cervical_cancer_incidence": 12.8,
|
|
"cervical_cancer_mortality": 5.8,
|
|
"income_level": "high",
|
|
"lives_saved_projected": 720,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 650
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [-74.0721, 4.7110] },
|
|
"properties": {
|
|
"name": "Colombia",
|
|
"hpv_coverage_2024": 59,
|
|
"vaccine_program_started": 2012,
|
|
"target_age": "9",
|
|
"cervical_cancer_incidence": 13.4,
|
|
"cervical_cancer_mortality": 6.1,
|
|
"income_level": "upper-middle",
|
|
"lives_saved_projected": 2800,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 1900
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [-78.1834, -1.8312] },
|
|
"properties": {
|
|
"name": "Ecuador",
|
|
"hpv_coverage_2024": 72,
|
|
"vaccine_program_started": 2014,
|
|
"target_age": "9",
|
|
"cervical_cancer_incidence": 17.3,
|
|
"cervical_cancer_mortality": 8.4,
|
|
"income_level": "upper-middle",
|
|
"lives_saved_projected": 920,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 840
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [-77.0428, -12.0464] },
|
|
"properties": {
|
|
"name": "Peru",
|
|
"hpv_coverage_2024": 75,
|
|
"vaccine_program_started": 2011,
|
|
"target_age": "9-13",
|
|
"cervical_cancer_incidence": 25.5,
|
|
"cervical_cancer_mortality": 11.4,
|
|
"income_level": "upper-middle",
|
|
"lives_saved_projected": 2600,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 2100
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [101.9758, 4.2105] },
|
|
"properties": {
|
|
"name": "Malaysia",
|
|
"hpv_coverage_2024": 82,
|
|
"vaccine_program_started": 2010,
|
|
"target_age": "13",
|
|
"cervical_cancer_incidence": 10.0,
|
|
"cervical_cancer_mortality": 4.6,
|
|
"income_level": "upper-middle",
|
|
"lives_saved_projected": 920,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 850
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [100.9925, 15.8700] },
|
|
"properties": {
|
|
"name": "Thailand",
|
|
"hpv_coverage_2024": 87,
|
|
"vaccine_program_started": 2017,
|
|
"target_age": "11",
|
|
"cervical_cancer_incidence": 9.7,
|
|
"cervical_cancer_mortality": 5.5,
|
|
"income_level": "upper-middle",
|
|
"lives_saved_projected": 1600,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 2200
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [37.6173, 55.7558] },
|
|
"properties": {
|
|
"name": "Russia",
|
|
"hpv_coverage_2024": 12,
|
|
"vaccine_program_started": 2023,
|
|
"target_age": "12-13",
|
|
"cervical_cancer_incidence": 15.4,
|
|
"cervical_cancer_mortality": 7.3,
|
|
"income_level": "upper-middle",
|
|
"lives_saved_projected": 12500,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 6300
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [104.1954, 35.8617] },
|
|
"properties": {
|
|
"name": "China",
|
|
"hpv_coverage_2024": 34,
|
|
"vaccine_program_started": 2022,
|
|
"target_age": "13-14",
|
|
"cervical_cancer_incidence": 11.0,
|
|
"cervical_cancer_mortality": 5.2,
|
|
"income_level": "upper-middle",
|
|
"lives_saved_projected": 52000,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 35000
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [34.8516, 31.0461] },
|
|
"properties": {
|
|
"name": "Israel",
|
|
"hpv_coverage_2024": 66,
|
|
"vaccine_program_started": 2013,
|
|
"target_age": "12-13",
|
|
"cervical_cancer_incidence": 5.1,
|
|
"cervical_cancer_mortality": 1.5,
|
|
"income_level": "high",
|
|
"lives_saved_projected": 180,
|
|
"gender_policy": "girls-and-boys",
|
|
"annual_deaths": 80
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [51.1839, 35.6892] },
|
|
"properties": {
|
|
"name": "Iran",
|
|
"hpv_coverage_2024": 41,
|
|
"vaccine_program_started": 2019,
|
|
"target_age": "12",
|
|
"cervical_cancer_incidence": 4.3,
|
|
"cervical_cancer_mortality": 2.4,
|
|
"income_level": "upper-middle",
|
|
"lives_saved_projected": 2400,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 1200
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [44.3661, 33.3128] },
|
|
"properties": {
|
|
"name": "Iraq",
|
|
"hpv_coverage_2024": 22,
|
|
"vaccine_program_started": 2021,
|
|
"target_age": "11",
|
|
"cervical_cancer_incidence": 3.8,
|
|
"cervical_cancer_mortality": 2.2,
|
|
"income_level": "upper-middle",
|
|
"lives_saved_projected": 950,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 520
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [35.2433, 38.9637] },
|
|
"properties": {
|
|
"name": "Turkey",
|
|
"hpv_coverage_2024": 73,
|
|
"vaccine_program_started": 2014,
|
|
"target_age": "11-12",
|
|
"cervical_cancer_incidence": 4.6,
|
|
"cervical_cancer_mortality": 2.1,
|
|
"income_level": "upper-middle",
|
|
"lives_saved_projected": 1800,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 1000
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [30.5234, 50.4501] },
|
|
"properties": {
|
|
"name": "Ukraine",
|
|
"hpv_coverage_2024": 24,
|
|
"vaccine_program_started": 2022,
|
|
"target_age": "11-12",
|
|
"cervical_cancer_incidence": 15.5,
|
|
"cervical_cancer_mortality": 7.6,
|
|
"income_level": "lower-middle",
|
|
"lives_saved_projected": 3800,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 1900
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [31.2357, -26.5225] },
|
|
"properties": {
|
|
"name": "Eswatini",
|
|
"hpv_coverage_2024": 91,
|
|
"vaccine_program_started": 2020,
|
|
"target_age": "10",
|
|
"cervical_cancer_incidence": 44.0,
|
|
"cervical_cancer_mortality": 30.4,
|
|
"income_level": "lower-middle",
|
|
"lives_saved_projected": 340,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 200
|
|
}
|
|
},
|
|
|
|
// SUB-SAHARAN AFRICA - VARYING COVERAGE
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [18.4241, -33.9249] },
|
|
"properties": {
|
|
"name": "South Africa",
|
|
"hpv_coverage_2024": 68,
|
|
"vaccine_program_started": 2014,
|
|
"target_age": "9",
|
|
"cervical_cancer_incidence": 38.2,
|
|
"cervical_cancer_mortality": 21.5,
|
|
"income_level": "upper-middle",
|
|
"lives_saved_projected": 9200,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 7400
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [32.2903, -15.8277] },
|
|
"properties": {
|
|
"name": "Malawi",
|
|
"hpv_coverage_2024": 86,
|
|
"vaccine_program_started": 2019,
|
|
"target_age": "9-13",
|
|
"cervical_cancer_incidence": 42.1,
|
|
"cervical_cancer_mortality": 27.9,
|
|
"income_level": "low",
|
|
"lives_saved_projected": 2100,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 1500
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [30.0619, -1.9403] },
|
|
"properties": {
|
|
"name": "Rwanda",
|
|
"hpv_coverage_2024": 93,
|
|
"vaccine_program_started": 2011,
|
|
"target_age": "12",
|
|
"cervical_cancer_incidence": 37.1,
|
|
"cervical_cancer_mortality": 24.3,
|
|
"income_level": "low",
|
|
"lives_saved_projected": 880,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 960
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [32.5732, 0.3476] },
|
|
"properties": {
|
|
"name": "Uganda",
|
|
"hpv_coverage_2024": 34,
|
|
"vaccine_program_started": 2015,
|
|
"target_age": "10",
|
|
"cervical_cancer_incidence": 40.1,
|
|
"cervical_cancer_mortality": 26.7,
|
|
"income_level": "low",
|
|
"lives_saved_projected": 6800,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 3900
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geography": { "type": "Point", "coordinates": [36.8219, -1.2864] },
|
|
"properties": {
|
|
"name": "Kenya",
|
|
"hpv_coverage_2024": 59,
|
|
"vaccine_program_started": 2019,
|
|
"target_age": "10",
|
|
"cervical_cancer_incidence": 31.9,
|
|
"cervical_cancer_mortality": 21.5,
|
|
"income_level": "lower-middle",
|
|
"lives_saved_projected": 5400,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 3100
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [29.8739, -3.3731] },
|
|
"properties": {
|
|
"name": "Burundi",
|
|
"hpv_coverage_2024": 76,
|
|
"vaccine_program_started": 2019,
|
|
"target_age": "9-13",
|
|
"cervical_cancer_incidence": 38.5,
|
|
"cervical_cancer_mortality": 25.8,
|
|
"income_level": "low",
|
|
"lives_saved_projected": 980,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 880
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [39.2083, -6.3690] },
|
|
"properties": {
|
|
"name": "Tanzania",
|
|
"hpv_coverage_2024": 82,
|
|
"vaccine_program_started": 2018,
|
|
"target_age": "9",
|
|
"cervical_cancer_incidence": 40.1,
|
|
"cervical_cancer_mortality": 27.6,
|
|
"income_level": "low",
|
|
"lives_saved_projected": 5900,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 5100
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [15.8277, -4.0383] },
|
|
"properties": {
|
|
"name": "Congo (DRC)",
|
|
"hpv_coverage_2024": 14,
|
|
"vaccine_program_started": 2023,
|
|
"target_age": "9-13",
|
|
"cervical_cancer_incidence": 36.7,
|
|
"cervical_cancer_mortality": 25.2,
|
|
"income_level": "low",
|
|
"lives_saved_projected": 11200,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 6800
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [9.7489, 6.5244] },
|
|
"properties": {
|
|
"name": "Nigeria",
|
|
"hpv_coverage_2024": 12,
|
|
"vaccine_program_started": 2023,
|
|
"target_age": "9-14",
|
|
"cervical_cancer_incidence": 32.7,
|
|
"cervical_cancer_mortality": 23.2,
|
|
"income_level": "lower-middle",
|
|
"lives_saved_projected": 26500,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 14500
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [-1.0232, 7.9465] },
|
|
"properties": {
|
|
"name": "Ghana",
|
|
"hpv_coverage_2024": 88,
|
|
"vaccine_program_started": 2013,
|
|
"target_age": "9",
|
|
"cervical_cancer_incidence": 35.3,
|
|
"cervical_cancer_mortality": 24.7,
|
|
"income_level": "lower-middle",
|
|
"lives_saved_projected": 2400,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 2200
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [-5.5471, 7.5400] },
|
|
"properties": {
|
|
"name": "Ivory Coast",
|
|
"hpv_coverage_2024": 72,
|
|
"vaccine_program_started": 2020,
|
|
"target_age": "9-13",
|
|
"cervical_cancer_incidence": 32.5,
|
|
"cervical_cancer_mortality": 22.8,
|
|
"income_level": "lower-middle",
|
|
"lives_saved_projected": 2800,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 1900
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [45.3182, 2.0469] },
|
|
"properties": {
|
|
"name": "Somalia",
|
|
"hpv_coverage_2024": 0,
|
|
"vaccine_program_started": null,
|
|
"target_age": null,
|
|
"cervical_cancer_incidence": 19.6,
|
|
"cervical_cancer_mortality": 14.8,
|
|
"income_level": "low",
|
|
"lives_saved_projected": 1400,
|
|
"gender_policy": null,
|
|
"annual_deaths": 790
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [38.7578, 9.1450] },
|
|
"properties": {
|
|
"name": "Ethiopia",
|
|
"hpv_coverage_2024": 56,
|
|
"vaccine_program_started": 2018,
|
|
"target_age": "14",
|
|
"cervical_cancer_incidence": 26.4,
|
|
"cervical_cancer_mortality": 18.4,
|
|
"income_level": "low",
|
|
"lives_saved_projected": 9800,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 6200
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [9.1021, 7.1881] },
|
|
"properties": {
|
|
"name": "Cameroon",
|
|
"hpv_coverage_2024": 64,
|
|
"vaccine_program_started": 2020,
|
|
"target_age": "9",
|
|
"cervical_cancer_incidence": 33.6,
|
|
"cervical_cancer_mortality": 23.4,
|
|
"income_level": "lower-middle",
|
|
"lives_saved_projected": 3100,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 2100
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [28.3228, -15.4167] },
|
|
"properties": {
|
|
"name": "Zambia",
|
|
"hpv_coverage_2024": 79,
|
|
"vaccine_program_started": 2013,
|
|
"target_age": "10-14",
|
|
"cervical_cancer_incidence": 40.6,
|
|
"cervical_cancer_mortality": 27.9,
|
|
"income_level": "lower-middle",
|
|
"lives_saved_projected": 2200,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 1600
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [29.1549, -19.0154] },
|
|
"properties": {
|
|
"name": "Zimbabwe",
|
|
"hpv_coverage_2024": 72,
|
|
"vaccine_program_started": 2018,
|
|
"target_age": "10-14",
|
|
"cervical_cancer_incidence": 37.8,
|
|
"cervical_cancer_mortality": 25.4,
|
|
"income_level": "lower-middle",
|
|
"lives_saved_projected": 1800,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 1200
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [24.6849, -12.1643] },
|
|
"properties": {
|
|
"name": "Angola",
|
|
"hpv_coverage_2024": 43,
|
|
"vaccine_program_started": 2021,
|
|
"target_age": "9",
|
|
"cervical_cancer_incidence": 28.3,
|
|
"cervical_cancer_mortality": 19.8,
|
|
"income_level": "lower-middle",
|
|
"lives_saved_projected": 2600,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 1500
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [17.8739, -22.5597] },
|
|
"properties": {
|
|
"name": "Namibia",
|
|
"hpv_coverage_2024": 84,
|
|
"vaccine_program_started": 2019,
|
|
"target_age": "9",
|
|
"cervical_cancer_incidence": 29.7,
|
|
"cervical_cancer_mortality": 19.2,
|
|
"income_level": "upper-middle",
|
|
"lives_saved_projected": 270,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 140
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [25.9231, -24.6282] },
|
|
"properties": {
|
|
"name": "Botswana",
|
|
"hpv_coverage_2024": 88,
|
|
"vaccine_program_started": 2015,
|
|
"target_age": "9",
|
|
"cervical_cancer_incidence": 34.5,
|
|
"cervical_cancer_mortality": 22.7,
|
|
"income_level": "upper-middle",
|
|
"lives_saved_projected": 290,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 180
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [47.5079, -18.8792] },
|
|
"properties": {
|
|
"name": "Madagascar",
|
|
"hpv_coverage_2024": 62,
|
|
"vaccine_program_started": 2020,
|
|
"target_age": "11-14",
|
|
"cervical_cancer_incidence": 29.6,
|
|
"cervical_cancer_mortality": 20.8,
|
|
"income_level": "low",
|
|
"lives_saved_projected": 2800,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 1700
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [55.5364, -20.8824] },
|
|
"properties": {
|
|
"name": "Mauritius",
|
|
"hpv_coverage_2024": 81,
|
|
"vaccine_program_started": 2016,
|
|
"target_age": "9",
|
|
"cervical_cancer_incidence": 15.3,
|
|
"cervical_cancer_mortality": 8.7,
|
|
"income_level": "upper-middle",
|
|
"lives_saved_projected": 95,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 35
|
|
}
|
|
},
|
|
|
|
// SOUTH ASIA - MODERATE TO LOW COVERAGE
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [78.9629, 20.5937] },
|
|
"properties": {
|
|
"name": "India",
|
|
"hpv_coverage_2024": 37,
|
|
"vaccine_program_started": 2022,
|
|
"target_age": "9-14",
|
|
"cervical_cancer_incidence": 14.7,
|
|
"cervical_cancer_mortality": 9.2,
|
|
"income_level": "lower-middle",
|
|
"lives_saved_projected": 86000,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 77000
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [90.3563, 23.6850] },
|
|
"properties": {
|
|
"name": "Bangladesh",
|
|
"hpv_coverage_2024": 28,
|
|
"vaccine_program_started": 2023,
|
|
"target_age": "10",
|
|
"cervical_cancer_incidence": 11.3,
|
|
"cervical_cancer_mortality": 7.8,
|
|
"income_level": "lower-middle",
|
|
"lives_saved_projected": 10500,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 6800
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [69.3451, 30.3753] },
|
|
"properties": {
|
|
"name": "Pakistan",
|
|
"hpv_coverage_2024": 18,
|
|
"vaccine_program_started": 2023,
|
|
"target_age": "9-13",
|
|
"cervical_cancer_incidence": 11.3,
|
|
"cervical_cancer_mortality": 7.9,
|
|
"income_level": "lower-middle",
|
|
"lives_saved_projected": 12300,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 7800
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [80.7718, 7.8731] },
|
|
"properties": {
|
|
"name": "Sri Lanka",
|
|
"hpv_coverage_2024": 76,
|
|
"vaccine_program_started": 2017,
|
|
"target_age": "10-11",
|
|
"cervical_cancer_incidence": 9.5,
|
|
"cervical_cancer_mortality": 5.4,
|
|
"income_level": "lower-middle",
|
|
"lives_saved_projected": 780,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 620
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [84.1240, 28.3949] },
|
|
"properties": {
|
|
"name": "Nepal",
|
|
"hpv_coverage_2024": 64,
|
|
"vaccine_program_started": 2016,
|
|
"target_age": "9-14",
|
|
"cervical_cancer_incidence": 16.2,
|
|
"cervical_cancer_mortality": 10.3,
|
|
"income_level": "lower-middle",
|
|
"lives_saved_projected": 2200,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 1500
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [90.4336, 27.5142] },
|
|
"properties": {
|
|
"name": "Bhutan",
|
|
"hpv_coverage_2024": 94,
|
|
"vaccine_program_started": 2010,
|
|
"target_age": "12",
|
|
"cervical_cancer_incidence": 11.4,
|
|
"cervical_cancer_mortality": 7.5,
|
|
"income_level": "lower-middle",
|
|
"lives_saved_projected": 42,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 22
|
|
}
|
|
},
|
|
|
|
// SOUTHEAST ASIA
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [113.9213, -0.7893] },
|
|
"properties": {
|
|
"name": "Indonesia",
|
|
"hpv_coverage_2024": 31,
|
|
"vaccine_program_started": 2022,
|
|
"target_age": "11",
|
|
"cervical_cancer_incidence": 17.2,
|
|
"cervical_cancer_mortality": 10.3,
|
|
"income_level": "lower-middle",
|
|
"lives_saved_projected": 24500,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 18000
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [121.7740, 12.8797] },
|
|
"properties": {
|
|
"name": "Philippines",
|
|
"hpv_coverage_2024": 4,
|
|
"vaccine_program_started": 2023,
|
|
"target_age": "9",
|
|
"cervical_cancer_incidence": 16.6,
|
|
"cervical_cancer_mortality": 10.1,
|
|
"income_level": "lower-middle",
|
|
"lives_saved_projected": 9200,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 7000
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [105.8342, 21.0278] },
|
|
"properties": {
|
|
"name": "Vietnam",
|
|
"hpv_coverage_2024": 76,
|
|
"vaccine_program_started": 2019,
|
|
"target_age": "9-13",
|
|
"cervical_cancer_incidence": 11.6,
|
|
"cervical_cancer_mortality": 6.8,
|
|
"income_level": "lower-middle",
|
|
"lives_saved_projected": 3800,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 3400
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [96.1951, 16.8661] },
|
|
"properties": {
|
|
"name": "Myanmar",
|
|
"hpv_coverage_2024": 19,
|
|
"vaccine_program_started": 2023,
|
|
"target_age": "9",
|
|
"cervical_cancer_incidence": 15.7,
|
|
"cervical_cancer_mortality": 10.6,
|
|
"income_level": "lower-middle",
|
|
"lives_saved_projected": 5200,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 3400
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [102.4955, 17.9757] },
|
|
"properties": {
|
|
"name": "Laos",
|
|
"hpv_coverage_2024": 68,
|
|
"vaccine_program_started": 2013,
|
|
"target_age": "9-13",
|
|
"cervical_cancer_incidence": 14.8,
|
|
"cervical_cancer_mortality": 9.9,
|
|
"income_level": "lower-middle",
|
|
"lives_saved_projected": 520,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 370
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [104.9910, 11.5564] },
|
|
"properties": {
|
|
"name": "Cambodia",
|
|
"hpv_coverage_2024": 71,
|
|
"vaccine_program_started": 2020,
|
|
"target_age": "9",
|
|
"cervical_cancer_incidence": 15.3,
|
|
"cervical_cancer_mortality": 10.1,
|
|
"income_level": "lower-middle",
|
|
"lives_saved_projected": 920,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 680
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [96.5851, 21.9162] },
|
|
"properties": {
|
|
"name": "Brunei",
|
|
"hpv_coverage_2024": 89,
|
|
"vaccine_program_started": 2009,
|
|
"target_age": "12",
|
|
"cervical_cancer_incidence": 8.2,
|
|
"cervical_cancer_mortality": 4.3,
|
|
"income_level": "high",
|
|
"lives_saved_projected": 18,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 12
|
|
}
|
|
},
|
|
|
|
// MIDDLE EAST & NORTH AFRICA
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [54.3773, 24.4539] },
|
|
"properties": {
|
|
"name": "United Arab Emirates",
|
|
"hpv_coverage_2024": 81,
|
|
"vaccine_program_started": 2018,
|
|
"target_age": "13-15",
|
|
"cervical_cancer_incidence": 5.7,
|
|
"cervical_cancer_mortality": 2.8,
|
|
"income_level": "high",
|
|
"lives_saved_projected": 110,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 45
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [46.7382, 24.7136] },
|
|
"properties": {
|
|
"name": "Saudi Arabia",
|
|
"hpv_coverage_2024": 67,
|
|
"vaccine_program_started": 2020,
|
|
"target_age": "13",
|
|
"cervical_cancer_incidence": 3.7,
|
|
"cervical_cancer_mortality": 1.8,
|
|
"income_level": "high",
|
|
"lives_saved_projected": 520,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 280
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [51.1839, 25.3548] },
|
|
"properties": {
|
|
"name": "Qatar",
|
|
"hpv_coverage_2024": 86,
|
|
"vaccine_program_started": 2011,
|
|
"target_age": "11",
|
|
"cervical_cancer_incidence": 6.8,
|
|
"cervical_cancer_mortality": 3.2,
|
|
"income_level": "high",
|
|
"lives_saved_projected": 28,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 18
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [53.8478, 23.4241] },
|
|
"properties": {
|
|
"name": "Oman",
|
|
"hpv_coverage_2024": 93,
|
|
"vaccine_program_started": 2020,
|
|
"target_age": "11",
|
|
"cervical_cancer_incidence": 4.2,
|
|
"cervical_cancer_mortality": 2.1,
|
|
"income_level": "high",
|
|
"lives_saved_projected": 58,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 38
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [50.5577, 26.0667] },
|
|
"properties": {
|
|
"name": "Bahrain",
|
|
"hpv_coverage_2024": 88,
|
|
"vaccine_program_started": 2018,
|
|
"target_age": "12",
|
|
"cervical_cancer_incidence": 6.1,
|
|
"cervical_cancer_mortality": 2.7,
|
|
"income_level": "high",
|
|
"lives_saved_projected": 22,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 12
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [47.4818, 29.3117] },
|
|
"properties": {
|
|
"name": "Kuwait",
|
|
"hpv_coverage_2024": 74,
|
|
"vaccine_program_started": 2017,
|
|
"target_age": "11-12",
|
|
"cervical_cancer_incidence": 6.2,
|
|
"cervical_cancer_mortality": 2.9,
|
|
"income_level": "high",
|
|
"lives_saved_projected": 65,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 38
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [10.1815, 36.8065] },
|
|
"properties": {
|
|
"name": "Tunisia",
|
|
"hpv_coverage_2024": 52,
|
|
"vaccine_program_started": 2019,
|
|
"target_age": "11",
|
|
"cervical_cancer_incidence": 6.9,
|
|
"cervical_cancer_mortality": 3.6,
|
|
"income_level": "lower-middle",
|
|
"lives_saved_projected": 520,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 240
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [-7.0926, 31.7917] },
|
|
"properties": {
|
|
"name": "Morocco",
|
|
"hpv_coverage_2024": 47,
|
|
"vaccine_program_started": 2022,
|
|
"target_age": "11",
|
|
"cervical_cancer_incidence": 13.8,
|
|
"cervical_cancer_mortality": 8.2,
|
|
"income_level": "lower-middle",
|
|
"lives_saved_projected": 2800,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 1700
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [1.6596, 28.0339] },
|
|
"properties": {
|
|
"name": "Algeria",
|
|
"hpv_coverage_2024": 38,
|
|
"vaccine_program_started": 2023,
|
|
"target_age": "11",
|
|
"cervical_cancer_incidence": 8.2,
|
|
"cervical_cancer_mortality": 5.1,
|
|
"income_level": "lower-middle",
|
|
"lives_saved_projected": 1900,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 1200
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [17.2283, 26.3351] },
|
|
"properties": {
|
|
"name": "Libya",
|
|
"hpv_coverage_2024": 0,
|
|
"vaccine_program_started": null,
|
|
"target_age": null,
|
|
"cervical_cancer_incidence": 4.4,
|
|
"cervical_cancer_mortality": 2.7,
|
|
"income_level": "upper-middle",
|
|
"lives_saved_projected": 180,
|
|
"gender_policy": null,
|
|
"annual_deaths": 98
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [30.8025, 26.8206] },
|
|
"properties": {
|
|
"name": "Egypt",
|
|
"hpv_coverage_2024": 0,
|
|
"vaccine_program_started": null,
|
|
"target_age": null,
|
|
"cervical_cancer_incidence": 3.2,
|
|
"cervical_cancer_mortality": 2.1,
|
|
"income_level": "lower-middle",
|
|
"lives_saved_projected": 2200,
|
|
"gender_policy": null,
|
|
"annual_deaths": 1200
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [35.8623, 33.8547] },
|
|
"properties": {
|
|
"name": "Lebanon",
|
|
"hpv_coverage_2024": 34,
|
|
"vaccine_program_started": 2023,
|
|
"target_age": "11",
|
|
"cervical_cancer_incidence": 7.3,
|
|
"cervical_cancer_mortality": 3.8,
|
|
"income_level": "upper-middle",
|
|
"lives_saved_projected": 280,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 150
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [38.9968, 34.8021] },
|
|
"properties": {
|
|
"name": "Syria",
|
|
"hpv_coverage_2024": 0,
|
|
"vaccine_program_started": null,
|
|
"target_age": null,
|
|
"cervical_cancer_incidence": 4.1,
|
|
"cervical_cancer_mortality": 2.6,
|
|
"income_level": "low",
|
|
"lives_saved_projected": 520,
|
|
"gender_policy": null,
|
|
"annual_deaths": 280
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [35.9456, 31.9522] },
|
|
"properties": {
|
|
"name": "Jordan",
|
|
"hpv_coverage_2024": 42,
|
|
"vaccine_program_started": 2023,
|
|
"target_age": "13",
|
|
"cervical_cancer_incidence": 3.9,
|
|
"cervical_cancer_mortality": 2.2,
|
|
"income_level": "upper-middle",
|
|
"lives_saved_projected": 240,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 130
|
|
}
|
|
},
|
|
|
|
// CENTRAL ASIA
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [66.9237, 48.0196] },
|
|
"properties": {
|
|
"name": "Kazakhstan",
|
|
"hpv_coverage_2024": 56,
|
|
"vaccine_program_started": 2013,
|
|
"target_age": "11",
|
|
"cervical_cancer_incidence": 19.9,
|
|
"cervical_cancer_mortality": 8.6,
|
|
"income_level": "upper-middle",
|
|
"lives_saved_projected": 1200,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 920
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [64.5853, 41.3775] },
|
|
"properties": {
|
|
"name": "Uzbekistan",
|
|
"hpv_coverage_2024": 48,
|
|
"vaccine_program_started": 2019,
|
|
"target_age": "11-12",
|
|
"cervical_cancer_incidence": 10.5,
|
|
"cervical_cancer_mortality": 5.8,
|
|
"income_level": "lower-middle",
|
|
"lives_saved_projected": 1800,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 1100
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [74.7661, 42.8746] },
|
|
"properties": {
|
|
"name": "Kyrgyzstan",
|
|
"hpv_coverage_2024": 62,
|
|
"vaccine_program_started": 2022,
|
|
"target_age": "11",
|
|
"cervical_cancer_incidence": 12.7,
|
|
"cervical_cancer_mortality": 6.9,
|
|
"income_level": "lower-middle",
|
|
"lives_saved_projected": 380,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 240
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [58.5601, 38.9697] },
|
|
"properties": {
|
|
"name": "Turkmenistan",
|
|
"hpv_coverage_2024": 0,
|
|
"vaccine_program_started": null,
|
|
"target_age": null,
|
|
"cervical_cancer_incidence": 8.6,
|
|
"cervical_cancer_mortality": 5.2,
|
|
"income_level": "upper-middle",
|
|
"lives_saved_projected": 320,
|
|
"gender_policy": null,
|
|
"annual_deaths": 180
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [71.2761, 38.8610] },
|
|
"properties": {
|
|
"name": "Tajikistan",
|
|
"hpv_coverage_2024": 43,
|
|
"vaccine_program_started": 2023,
|
|
"target_age": "11",
|
|
"cervical_cancer_incidence": 9.8,
|
|
"cervical_cancer_mortality": 6.1,
|
|
"income_level": "lower-middle",
|
|
"lives_saved_projected": 520,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 320
|
|
}
|
|
},
|
|
|
|
// LATIN AMERICA & CARIBBEAN
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [-56.0272, -34.9011] },
|
|
"properties": {
|
|
"name": "Uruguay",
|
|
"hpv_coverage_2024": 89,
|
|
"vaccine_program_started": 2013,
|
|
"target_age": "12",
|
|
"cervical_cancer_incidence": 15.9,
|
|
"cervical_cancer_mortality": 6.1,
|
|
"income_level": "high",
|
|
"lives_saved_projected": 380,
|
|
"gender_policy": "girls-and-boys",
|
|
"annual_deaths": 130
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [-56.0275, -25.2637] },
|
|
"properties": {
|
|
"name": "Paraguay",
|
|
"hpv_coverage_2024": 76,
|
|
"vaccine_program_started": 2013,
|
|
"target_age": "9-13",
|
|
"cervical_cancer_incidence": 26.8,
|
|
"cervical_cancer_mortality": 12.1,
|
|
"income_level": "upper-middle",
|
|
"lives_saved_projected": 920,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 490
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [-63.5887, -16.2902] },
|
|
"properties": {
|
|
"name": "Bolivia",
|
|
"hpv_coverage_2024": 68,
|
|
"vaccine_program_started": 2017,
|
|
"target_age": "10-12",
|
|
"cervical_cancer_incidence": 28.2,
|
|
"cervical_cancer_mortality": 13.8,
|
|
"income_level": "lower-middle",
|
|
"lives_saved_projected": 1400,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 940
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [-75.0152, 4.0989] },
|
|
"properties": {
|
|
"name": "Venezuela",
|
|
"hpv_coverage_2024": 23,
|
|
"vaccine_program_started": 2008,
|
|
"target_age": "9",
|
|
"cervical_cancer_incidence": 19.4,
|
|
"cervical_cancer_mortality": 10.2,
|
|
"income_level": "upper-middle",
|
|
"lives_saved_projected": 3800,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 1800
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [-88.8965, 13.7942] },
|
|
"properties": {
|
|
"name": "El Salvador",
|
|
"hpv_coverage_2024": 82,
|
|
"vaccine_program_started": 2019,
|
|
"target_age": "10",
|
|
"cervical_cancer_incidence": 18.5,
|
|
"cervical_cancer_mortality": 9.2,
|
|
"income_level": "lower-middle",
|
|
"lives_saved_projected": 620,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 340
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [-90.2308, 15.7835] },
|
|
"properties": {
|
|
"name": "Guatemala",
|
|
"hpv_coverage_2024": 64,
|
|
"vaccine_program_started": 2018,
|
|
"target_age": "10",
|
|
"cervical_cancer_incidence": 24.3,
|
|
"cervical_cancer_mortality": 12.8,
|
|
"income_level": "upper-middle",
|
|
"lives_saved_projected": 2400,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 1300
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [-86.2419, 12.8654] },
|
|
"properties": {
|
|
"name": "Nicaragua",
|
|
"hpv_coverage_2024": 89,
|
|
"vaccine_program_started": 2008,
|
|
"target_age": "10",
|
|
"cervical_cancer_incidence": 22.6,
|
|
"cervical_cancer_mortality": 11.9,
|
|
"income_level": "lower-middle",
|
|
"lives_saved_projected": 680,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 460
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [-87.2068, 14.0650] },
|
|
"properties": {
|
|
"name": "Honduras",
|
|
"hpv_coverage_2024": 78,
|
|
"vaccine_program_started": 2016,
|
|
"target_age": "10",
|
|
"cervical_cancer_incidence": 20.7,
|
|
"cervical_cancer_mortality": 11.3,
|
|
"income_level": "lower-middle",
|
|
"lives_saved_projected": 980,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 640
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [-84.0907, 9.7489] },
|
|
"properties": {
|
|
"name": "Costa Rica",
|
|
"hpv_coverage_2024": 91,
|
|
"vaccine_program_started": 2019,
|
|
"target_age": "10",
|
|
"cervical_cancer_incidence": 11.8,
|
|
"cervical_cancer_mortality": 5.7,
|
|
"income_level": "upper-middle",
|
|
"lives_saved_projected": 320,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 170
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [-80.7821, 8.5380] },
|
|
"properties": {
|
|
"name": "Panama",
|
|
"hpv_coverage_2024": 86,
|
|
"vaccine_program_started": 2008,
|
|
"target_age": "10",
|
|
"cervical_cancer_incidence": 17.4,
|
|
"cervical_cancer_mortality": 8.9,
|
|
"income_level": "high",
|
|
"lives_saved_projected": 380,
|
|
"gender_policy": "girls-and-boys",
|
|
"annual_deaths": 220
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [-88.4966, 17.1899] },
|
|
"properties": {
|
|
"name": "Belize",
|
|
"hpv_coverage_2024": 74,
|
|
"vaccine_program_started": 2017,
|
|
"target_age": "11",
|
|
"cervical_cancer_incidence": 28.4,
|
|
"cervical_cancer_mortality": 15.7,
|
|
"income_level": "upper-middle",
|
|
"lives_saved_projected": 68,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 32
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [-61.3789, 10.6918] },
|
|
"properties": {
|
|
"name": "Trinidad and Tobago",
|
|
"hpv_coverage_2024": 68,
|
|
"vaccine_program_started": 2013,
|
|
"target_age": "11-12",
|
|
"cervical_cancer_incidence": 21.2,
|
|
"cervical_cancer_mortality": 11.8,
|
|
"income_level": "high",
|
|
"lives_saved_projected": 180,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 95
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [-77.2975, 18.1096] },
|
|
"properties": {
|
|
"name": "Jamaica",
|
|
"hpv_coverage_2024": 71,
|
|
"vaccine_program_started": 2017,
|
|
"target_age": "11",
|
|
"cervical_cancer_incidence": 22.3,
|
|
"cervical_cancer_mortality": 12.4,
|
|
"income_level": "upper-middle",
|
|
"lives_saved_projected": 420,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 220
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [-72.2852, 18.9712] },
|
|
"properties": {
|
|
"name": "Haiti",
|
|
"hpv_coverage_2024": 16,
|
|
"vaccine_program_started": 2016,
|
|
"target_age": "9",
|
|
"cervical_cancer_incidence": 23.4,
|
|
"cervical_cancer_mortality": 15.8,
|
|
"income_level": "low",
|
|
"lives_saved_projected": 1900,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 1100
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [-70.1627, 18.7357] },
|
|
"properties": {
|
|
"name": "Dominican Republic",
|
|
"hpv_coverage_2024": 63,
|
|
"vaccine_program_started": 2019,
|
|
"target_age": "9",
|
|
"cervical_cancer_incidence": 18.7,
|
|
"cervical_cancer_mortality": 10.3,
|
|
"income_level": "upper-middle",
|
|
"lives_saved_projected": 820,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 660
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [-66.1057, 18.2208] },
|
|
"properties": {
|
|
"name": "Puerto Rico",
|
|
"hpv_coverage_2024": 78,
|
|
"vaccine_program_started": 2006,
|
|
"target_age": "11-12",
|
|
"cervical_cancer_incidence": 9.8,
|
|
"cervical_cancer_mortality": 3.2,
|
|
"income_level": "high",
|
|
"lives_saved_projected": 220,
|
|
"gender_policy": "girls-and-boys",
|
|
"annual_deaths": 65
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [-61.5510, 15.3092] },
|
|
"properties": {
|
|
"name": "Guyana",
|
|
"hpv_coverage_2024": 82,
|
|
"vaccine_program_started": 2013,
|
|
"target_age": "9-13",
|
|
"cervical_cancer_incidence": 27.8,
|
|
"cervical_cancer_mortality": 16.2,
|
|
"income_level": "upper-middle",
|
|
"lives_saved_projected": 120,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 78
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [-55.1679, 3.9194] },
|
|
"properties": {
|
|
"name": "Suriname",
|
|
"hpv_coverage_2024": 76,
|
|
"vaccine_program_started": 2013,
|
|
"target_age": "10",
|
|
"cervical_cancer_incidence": 23.5,
|
|
"cervical_cancer_mortality": 14.1,
|
|
"income_level": "upper-middle",
|
|
"lives_saved_projected": 85,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 48
|
|
}
|
|
},
|
|
|
|
// PACIFIC ISLANDS
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [178.6650, -17.7134] },
|
|
"properties": {
|
|
"name": "Fiji",
|
|
"hpv_coverage_2024": 88,
|
|
"vaccine_program_started": 2008,
|
|
"target_age": "9-12",
|
|
"cervical_cancer_incidence": 19.2,
|
|
"cervical_cancer_mortality": 11.6,
|
|
"income_level": "upper-middle",
|
|
"lives_saved_projected": 92,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 62
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [147.1803, -9.4438] },
|
|
"properties": {
|
|
"name": "Papua New Guinea",
|
|
"hpv_coverage_2024": 42,
|
|
"vaccine_program_started": 2016,
|
|
"target_age": "9-14",
|
|
"cervical_cancer_incidence": 29.4,
|
|
"cervical_cancer_mortality": 20.8,
|
|
"income_level": "lower-middle",
|
|
"lives_saved_projected": 1800,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 980
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [166.9315, -0.5228] },
|
|
"properties": {
|
|
"name": "Kiribati",
|
|
"hpv_coverage_2024": 79,
|
|
"vaccine_program_started": 2019,
|
|
"target_age": "9",
|
|
"cervical_cancer_incidence": 21.7,
|
|
"cervical_cancer_mortality": 14.9,
|
|
"income_level": "lower-middle",
|
|
"lives_saved_projected": 28,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 15
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [168.3273, -17.7333] },
|
|
"properties": {
|
|
"name": "Vanuatu",
|
|
"hpv_coverage_2024": 84,
|
|
"vaccine_program_started": 2013,
|
|
"target_age": "9-13",
|
|
"cervical_cancer_incidence": 18.3,
|
|
"cervical_cancer_mortality": 12.4,
|
|
"income_level": "lower-middle",
|
|
"lives_saved_projected": 42,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 22
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [160.1562, -9.6457] },
|
|
"properties": {
|
|
"name": "Solomon Islands",
|
|
"hpv_coverage_2024": 73,
|
|
"vaccine_program_started": 2015,
|
|
"target_age": "9-13",
|
|
"cervical_cancer_incidence": 22.6,
|
|
"cervical_cancer_mortality": 15.8,
|
|
"income_level": "lower-middle",
|
|
"lives_saved_projected": 78,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 48
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [-171.8558, -13.7590] },
|
|
"properties": {
|
|
"name": "Samoa",
|
|
"hpv_coverage_2024": 86,
|
|
"vaccine_program_started": 2015,
|
|
"target_age": "9-11",
|
|
"cervical_cancer_incidence": 17.4,
|
|
"cervical_cancer_mortality": 11.2,
|
|
"income_level": "lower-middle",
|
|
"lives_saved_projected": 28,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 14
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [-175.1982, -21.1789] },
|
|
"properties": {
|
|
"name": "Tonga",
|
|
"hpv_coverage_2024": 91,
|
|
"vaccine_program_started": 2013,
|
|
"target_age": "9-12",
|
|
"cervical_cancer_incidence": 16.8,
|
|
"cervical_cancer_mortality": 10.7,
|
|
"income_level": "upper-middle",
|
|
"lives_saved_projected": 18,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 8
|
|
}
|
|
},
|
|
|
|
// ADDITIONAL EUROPEAN COUNTRIES
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [19.5033, 47.1625] },
|
|
"properties": {
|
|
"name": "Hungary",
|
|
"hpv_coverage_2024": 62,
|
|
"vaccine_program_started": 2014,
|
|
"target_age": "12",
|
|
"cervical_cancer_incidence": 15.2,
|
|
"cervical_cancer_mortality": 6.8,
|
|
"income_level": "high",
|
|
"lives_saved_projected": 680,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 400
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [19.1451, 48.6690] },
|
|
"properties": {
|
|
"name": "Slovakia",
|
|
"hpv_coverage_2024": 48,
|
|
"vaccine_program_started": 2012,
|
|
"target_age": "12",
|
|
"cervical_cancer_incidence": 16.8,
|
|
"cervical_cancer_mortality": 7.9,
|
|
"income_level": "high",
|
|
"lives_saved_projected": 520,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 260
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [15.4729, 49.8175] },
|
|
"properties": {
|
|
"name": "Czech Republic",
|
|
"hpv_coverage_2024": 57,
|
|
"vaccine_program_started": 2012,
|
|
"target_age": "13",
|
|
"cervical_cancer_incidence": 14.3,
|
|
"cervical_cancer_mortality": 5.8,
|
|
"income_level": "high",
|
|
"lives_saved_projected": 520,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 370
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [14.5058, 46.1512] },
|
|
"properties": {
|
|
"name": "Slovenia",
|
|
"hpv_coverage_2024": 66,
|
|
"vaccine_program_started": 2009,
|
|
"target_age": "11-12",
|
|
"cervical_cancer_incidence": 14.2,
|
|
"cervical_cancer_mortality": 5.3,
|
|
"income_level": "high",
|
|
"lives_saved_projected": 120,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 65
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [15.9819, 45.1000] },
|
|
"properties": {
|
|
"name": "Croatia",
|
|
"hpv_coverage_2024": 72,
|
|
"vaccine_program_started": 2016,
|
|
"target_age": "11-12",
|
|
"cervical_cancer_incidence": 18.3,
|
|
"cervical_cancer_mortality": 7.6,
|
|
"income_level": "high",
|
|
"lives_saved_projected": 280,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 190
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature">
|
|
"geometry": { "type": "Point", "coordinates": [20.9429, 44.0165] },
|
|
"properties": {
|
|
"name": "Serbia",
|
|
"hpv_coverage_2024": 43,
|
|
"vaccine_program_started": 2020,
|
|
"target_age": "12",
|
|
"cervical_cancer_incidence": 21.8,
|
|
"cervical_cancer_mortality": 10.2,
|
|
"income_level": "upper-middle",
|
|
"lives_saved_projected": 780,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 420
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [21.0059, 42.6507] },
|
|
"properties": {
|
|
"name": "North Macedonia",
|
|
"hpv_coverage_2024": 38,
|
|
"vaccine_program_started": 2023,
|
|
"target_age": "12",
|
|
"cervical_cancer_incidence": 19.7,
|
|
"cervical_cancer_mortality": 9.8,
|
|
"income_level": "upper-middle",
|
|
"lives_saved_projected": 280,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 120
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [19.8187, 41.1533] },
|
|
"properties": {
|
|
"name": "Albania",
|
|
"hpv_coverage_2024": 47,
|
|
"vaccine_program_started": 2022,
|
|
"target_age": "11",
|
|
"cervical_cancer_incidence": 13.7,
|
|
"cervical_cancer_mortality": 7.2,
|
|
"income_level": "upper-middle",
|
|
"lives_saved_projected": 240,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 120
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [23.3219, 42.7339] },
|
|
"properties": {
|
|
"name": "Bulgaria",
|
|
"hpv_coverage_2024": 34,
|
|
"vaccine_program_started": 2012,
|
|
"target_age": "12",
|
|
"cervical_cancer_incidence": 21.2,
|
|
"cervical_cancer_mortality": 10.6,
|
|
"income_level": "upper-middle",
|
|
"lives_saved_projected": 920,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 440
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [23.7275, 37.9838] },
|
|
"properties": {
|
|
"name": "Greece",
|
|
"hpv_coverage_2024": 58,
|
|
"vaccine_program_started": 2008,
|
|
"target_age": "12-15",
|
|
"cervical_cancer_incidence": 7.7,
|
|
"cervical_cancer_mortality": 2.7,
|
|
"income_level": "high",
|
|
"lives_saved_projected": 420,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 180
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [-8.2245, 39.3999] },
|
|
"properties": {
|
|
"name": "Portugal",
|
|
"hpv_coverage_2024": 89,
|
|
"vaccine_program_started": 2008,
|
|
"target_age": "10-13",
|
|
"cervical_cancer_incidence": 11.9,
|
|
"cervical_cancer_mortality": 3.7,
|
|
"income_level": "high",
|
|
"lives_saved_projected": 340,
|
|
"gender_policy": "girls-and-boys",
|
|
"annual_deaths": 230
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [14.1258, 52.2297] },
|
|
"properties": {
|
|
"name": "Austria",
|
|
"hpv_coverage_2024": 64,
|
|
"vaccine_program_started": 2014,
|
|
"target_age": "9-12",
|
|
"cervical_cancer_incidence": 9.5,
|
|
"cervical_cancer_mortality": 3.2,
|
|
"income_level": "high",
|
|
"lives_saved_projected": 320,
|
|
"gender_policy": "girls-and-boys",
|
|
"annual_deaths": 170
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [24.9384, 60.1695] },
|
|
"properties": {
|
|
"name": "Estonia",
|
|
"hpv_coverage_2024": 71,
|
|
"vaccine_program_started": 2018,
|
|
"target_age": "12-14",
|
|
"cervical_cancer_incidence": 13.2,
|
|
"cervical_cancer_mortality": 5.1,
|
|
"income_level": "high",
|
|
"lives_saved_projected": 85,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 40
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [24.1052, 56.8796] },
|
|
"properties": {
|
|
"name": "Latvia",
|
|
"hpv_coverage_2024": 66,
|
|
"vaccine_program_started": 2010,
|
|
"target_age": "12",
|
|
"cervical_cancer_incidence": 16.8,
|
|
"cervical_cancer_mortality": 7.3,
|
|
"income_level": "high",
|
|
"lives_saved_projected": 150,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 82
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [23.8813, 54.5260] },
|
|
"properties": {
|
|
"name": "Lithuania",
|
|
"hpv_coverage_2024": 58,
|
|
"vaccine_program_started": 2016,
|
|
"target_age": "11-12",
|
|
"cervical_cancer_incidence": 18.7,
|
|
"cervical_cancer_mortality": 7.9,
|
|
"income_level": "high",
|
|
"lives_saved_projected": 220,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 130
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [6.1296, 49.8153] },
|
|
"properties": {
|
|
"name": "Luxembourg",
|
|
"hpv_coverage_2024": 79,
|
|
"vaccine_program_started": 2008,
|
|
"target_age": "11-13",
|
|
"cervical_cancer_incidence": 8.4,
|
|
"cervical_cancer_mortality": 2.5,
|
|
"income_level": "high",
|
|
"lives_saved_projected": 28,
|
|
"gender_policy": "girls-only",
|
|
"annual_deaths": 9
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [-6.2603, 53.4129] },
|
|
"properties": {
|
|
"name": "Ireland",
|
|
"hpv_coverage_2024": 76,
|
|
"vaccine_program_started": 2010,
|
|
"target_age": "12-13",
|
|
"cervical_cancer_incidence": 11.4,
|
|
"cervical_cancer_mortality": 3.8,
|
|
"income_level": "high",
|
|
"lives_saved_projected": 210,
|
|
"gender_policy": "girls-and-boys",
|
|
"annual_deaths": 110
|
|
}
|
|
},
|
|
{
|
|
"type": "Feature",
|
|
"geometry": { "type": "Point", "coordinates": [-18.7669, 64.9631] },
|
|
"properties": {
|
|
"name": "Iceland",
|
|
"hpv_coverage_2024": 87,
|
|
"vaccine_program_started": 2011,
|
|
"target_age": "12",
|
|
"cervical_cancer_incidence": 9.2,
|
|
"cervical_cancer_mortality": 2.8,
|
|
"income_level": "high",
|
|
"lives_saved_projected": 12,
|
|
"gender_policy": "girls-and-boys",
|
|
"annual_deaths": 6
|
|
}
|
|
}
|
|
]
|
|
};
|
|
|
|
// Global statistics helper function
|
|
function getGlobalStatistics() {
|
|
const features = hpvVaccineData.features;
|
|
|
|
const totalCountries = features.length;
|
|
const countriesWithPrograms = features.filter(f => f.properties.hpv_coverage_2024 > 0).length;
|
|
|
|
const avgCoverage = features.reduce((sum, f) => sum + f.properties.hpv_coverage_2024, 0) / totalCountries;
|
|
|
|
const highIncome = features.filter(f => f.properties.income_level === 'high');
|
|
const avgHighIncomeCoverage = highIncome.reduce((sum, f) => sum + f.properties.hpv_coverage_2024, 0) / highIncome.length;
|
|
|
|
const lowIncome = features.filter(f => f.properties.income_level === 'low');
|
|
const avgLowIncomeCoverage = lowIncome.reduce((sum, f) => sum + f.properties.hpv_coverage_2024, 0) / lowIncome.length;
|
|
|
|
const totalLivesSaved = features.reduce((sum, f) => sum + f.properties.lives_saved_projected, 0);
|
|
|
|
const totalAnnualDeaths = features.reduce((sum, f) => sum + f.properties.annual_deaths, 0);
|
|
|
|
return {
|
|
totalCountries,
|
|
countriesWithPrograms,
|
|
avgCoverage: Math.round(avgCoverage),
|
|
avgHighIncomeCoverage: Math.round(avgHighIncomeCoverage),
|
|
avgLowIncomeCoverage: Math.round(avgLowIncomeCoverage),
|
|
totalLivesSaved: Math.round(totalLivesSaved),
|
|
totalAnnualDeaths: Math.round(totalAnnualDeaths)
|
|
};
|
|
}
|